Medication info
Telmisartan Plus Tablets 40/12.5 Milligrams

Telmisartan Plus Tablets 40/12.5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White or nearly white-red, oval-shaped tablet consisting of two layers, with possible red spots on the white layer.
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201000865 · Notified 2010.01.26 · Insurance code 643305660

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this fixed-dose combination, it is recommended that the dose of each component be individually adjusted separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension when blood pressure control is insufficient with monotherapy with telmisartan alone. It effectively lowers blood pressure and reduces the risk of cardiovascular complications. Therefore, it is a medication that helps in the treatment of hypertension.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this fixed-dose combination, it is recommended that the dose of each component be individually adjusted separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious side effects to the fetus or newborn. It is contraindicated for individuals with allergies to this medication or its excipients, hypersensitivity to sulfonamide drugs, pregnant or nursing women, patients with cholestasis or obstructive biliary diseases, severe liver or kidney impairment, acute glomerulonephritis, anuria, certain electrolyte imbalances, etc. Elderly patients, patients with hyperkalemia, those with mild to moderate liver impairment, heart valve disease, ischemic heart disease, gastrointestinal diseases, and renal artery hypertension should use this medication with extra caution. This medication can lower blood pressure, so symptoms such as dizziness, hypotension, and fainting may occur, particularly during driving or operating machinery. The hydrochlorothiazide component can cause fluid and electrolyte imbalances, leading to symptoms such as dry mouth, muscle cramps, and weakness, so regular blood tests to monitor electrolyte status are necessary. This medication can interact with other drugs; therefore, it is important to consult a doctor before taking it with lithium, potassium-sparing agents, diuretics, nonsteroidal anti-inflammatory drugs, antiarrhythmics, antidiabetics, etc., and to monitor blood pressure, kidney function, and serum potassium levels regularly. This medication should be discontinued as soon as possible during pregnancy, and it is advisable not to use it while breastfeeding. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dehydration may occur, so seeking immediate medical care is necessary for appropriate treatment. This medication is not recommended for children under 18 years of age, as safety and efficacy have not been established. For elderly patients, there may be a risk of excessively low blood pressure leading to stroke, so careful monitoring is essential during use. When using this medication, keep it out of reach of children, and do not transfer it into other containers for safety.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 111 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory pain
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • indigestion
  • vomiting
  • gastritis
  • liver function abnormality
  • liver disorder
  • vascular edema
  • erythema
  • pruritus
  • rash
  • diaphoresis
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • pain in the limbs
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disorder
  • eczema
  • drug rash
  • toxic skin rash
  • joint pain
  • kidney dysfunction
  • asthenia
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • increased liver enzymes
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • asthenia
  • fever
  • nausea
  • abdominal pain
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • proteinuria
  • itching
  • myalgia
  • sensation of floating
  • lip and hand tremors
  • hypersensitivity
  • decreased vision
  • hypoglycemia
  • intestinal vascular edema
  • nausea
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1°C and 30°C, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

White or nearly white-red, oval-shaped tablet consisting of two layers, with possible red spots on the white layer.

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.